Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

131 ARTÍCULOS , VIENDO DEL 31 AL 45

Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects

Cantero JL, Iglesias JE, Van Leemput K, Atienza M.

J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1210-5. doi: 10.1093/gerona/glw022. Epub 2016 Mar 4.

ZCWPW1 is associated with late-onset Alzheimer's disease in Han Chinese: a replication study and meta-analyses

Gao Y, Tan MS, Wang HF, Zhang W, Wang ZX, Jiang T, Yu JT, Tan L.

Oncotarget. 2016 Apr 12;7(15):20305-11. doi: 10.18632/oncotarget.7945.

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

Landau SM, Horng A, Fero A, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Apr 12;86(15):1377-1385. doi: 10.1212/WNL.0000000000002576. Epub 2016 Mar 11.

Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease

Wilke C, Gillardon F, Deuschle C, Dubois E, Hobert MA, Müller vom Hagen J, Krüger S, Biskup S, Blauwendraat C, Hruscha M, Kaeser SA, Heutink P, Maetzler W, Synofzik M.

Curr Alzheimer Res. 2016;13(6):654-62. doi: 10.2174/1567205013666160314151247.

Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration

Wang HF, Wan Y, Hao XK, Cao L, Zhu XC, Jiang T, Tan MS, Tan L, Zhang DQ, Tan L, Yu JT; Disease Neuroimaging Initiative Alzheimer’s.

J Alzheimers Dis. 2016 Mar 15;52(1):179-90. doi: 10.3233/JAD-150972.

[Alzheimer's disease and Helicobacter pylori infection: a possible link?]

Roubaud Baudron C, Varon C, Mégraud F, Salles N.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Mar;14(1):86-94. doi: 10.1684/pnv.2016.0584.

Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study

Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC.

Neurology. 2016 Apr 19;86(16):1499-506. doi: 10.1212/WNL.0000000000002593. Epub 2016 Mar 23.

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

Wang J, Logovinsky V, Hendrix SB, Stanworth SH, Perdomo C, Xu L, Dhadda S, Do I, Rabe M, Luthman J, Cummings J, Satlin A.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):993-9. doi: 10.1136/jnnp-2015-312383. Epub 2016 Mar 23.

White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, Ryan NS, Förster S, Laske C, Schofield PR, Sperling RA, Salloway S, Correia S, Jack C Jr, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AM; Dominantly Inherited Alzheimer Network.

Ann Neurol. 2016 Jun;79(6):929-39. doi: 10.1002/ana.24647. Epub 2016 Apr 27.

Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology

Yu L, Chibnik LB, Yang J, McCabe C, Xu J, Schneider JA, De Jager PL, Bennett DA.

Alzheimers Dement. 2016 Sep;12(9):942-951. doi: 10.1016/j.jalz.2016.02.009. Epub 2016 Mar 24.

Cerebrospinal Biomarkers in Alzheimer Disease-Potential Roles as Markers of Prognosis and Neuroplasticity

DeKosky ST, Golde T.

JAMA Neurol. 2016 May 1;73(5):508-10. doi: 10.1001/jamaneurol.2016.0090.

Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress

Ali MR, Abo-Youssef AM, Messiha BA, Khattab MM.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Jun;389(6):637-56. doi: 10.1007/s00210-016-1234-6. Epub 2016 Mar 30.

Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody

Logovinsky V, Satlin A, Lai R, Swanson C, Kaplow J, Osswald G, Basun H, Lannfelt L.

Alzheimers Res Ther. 2016 Apr 6;8(1):14. doi: 10.1186/s13195-016-0181-2.

[Development of Disease-modifying Therapy for Alzheimer's Disease]

Akiyama H.

Brain Nerve. 2016 Apr;68(4):463-72. doi: 10.11477/mf.1416200419.

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H.

Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias